Lung Cancer with MET exon 14 Skipping Mutation: Genetic Feature, Current Treatments, and Future Challenges

Lung Cancer with MET exon 14 Skipping Mutation: Genetic Feature, Current Treatments, and Future Challenges

Toshio Fujino, Kenichi Suda, Tetsuya Mitsudomi Division of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine, Osaka-Sayama, JapanCorrespondence: Tetsuya MitsudomiKindai University Faculty of Medicine, Division of Thoracic Surgery, Department of Surgery, 377-2 Ohno-Higash...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fujino T, Suda K, Mitsudomi T
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
non-small cell lung cancer
met exon 14 skipping
capmatinib
tepotinib
resistance mechanisms
immune checkpoint inhibitors
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/f984ebd2259242cf97186c7a243e1fc5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/f984ebd2259242cf97186c7a243e1fc5

Ejemplares similares